| |
 |
|
Class Information
Number: 514/315
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines
Description: Subject matter wherein the six-membered hetero ring, consisting of one nitrogen and five carbons, contains no double bonds between ring members, i.e., the piperidine ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6710040 |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
Mar. 23, 2004 |
| 6703425 |
Sulfonamide derivatives |
Mar. 9, 2004 |
| 6703383 |
Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
Mar. 9, 2004 |
| 6699890 |
Phosphodiesterase 4 inhibitors |
Mar. 2, 2004 |
| 6696440 |
Treatment of asthma with MEK inhibitors |
Feb. 24, 2004 |
| 6673365 |
Formulation for treatment of thromboembolism |
Jan. 6, 2004 |
| 6667317 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
Dec. 23, 2003 |
| 6667342 |
Benzenesulfonamide-derivatives and their use as medicaments |
Dec. 23, 2003 |
| 6664253 |
Neurokinin antagonists |
Dec. 16, 2003 |
| 6664259 |
Il-8 receptor antagonists |
Dec. 16, 2003 |
| 6660741 |
Asymmetric synthesis of (S,S,R)-(-)-actinonin and its analogs and uses therefor |
Dec. 9, 2003 |
| 6660749 |
Inhibition of glycolipid biosynthesis |
Dec. 9, 2003 |
| 6656964 |
Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids |
Dec. 2, 2003 |
| 6653324 |
Stabilization of wood substrates |
Nov. 25, 2003 |
| 6653321 |
Naphthylsulfonic acids and related compounds as glucose uptake agonists |
Nov. 25, 2003 |
| 6645990 |
Thiazolyl urea compounds and methods of uses |
Nov. 11, 2003 |
| 6630490 |
Methods for treatment of disease-induced peripheral neuropathy and related conditions |
Oct. 7, 2003 |
| 6620806 |
Methods and kits for improving vascular health |
Sep. 16, 2003 |
| 6617337 |
Use of nitroxides for the treatment of essential hypertension |
Sep. 9, 2003 |
| 6617322 |
Preferentially substituted calcium channel blockers |
Sep. 9, 2003 |
| 6613796 |
Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions |
Sep. 2, 2003 |
| 6610703 |
Method for treatment of glycolipid storage diseases |
Aug. 26, 2003 |
| 6610678 |
CRF antagonistic quino-and quinazolines |
Aug. 26, 2003 |
| 6605619 |
Nitroxides as protectors against oxidatives stress |
Aug. 12, 2003 |
| 6599919 |
Method for enhancing mutant enzyme activities in lysosomal storage disorders |
Jul. 29, 2003 |
| 6589964 |
Method for enhancing mutant enzyme activities in lysosomal storage disorders |
Jul. 8, 2003 |
| 6586438 |
Antidiabetic formulation and method |
Jul. 1, 2003 |
| 6583158 |
Method for enhancing mutant enzyme activities in lysosomal storage disorders |
Jun. 24, 2003 |
| 6579896 |
Method for treating allergies using substituted pyrazoles |
Jun. 17, 2003 |
| 6569862 |
Methods for treatment of disorders of cardiac contractility |
May. 27, 2003 |
| 6566374 |
Method of treating or preventing microbial infections with loperamide |
May. 20, 2003 |
| 6562841 |
Methods and compositions for repelling arthropods |
May. 13, 2003 |
| 6559164 |
Substituted pyrroles suitable for continuous infusion |
May. 6, 2003 |
| 6559144 |
Bicyclic amino acids |
May. 6, 2003 |
| 6555569 |
Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection |
Apr. 29, 2003 |
| 6552040 |
Use of nitroxides in wound healing and in the prevention of photodamage |
Apr. 22, 2003 |
| 6552014 |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors |
Apr. 22, 2003 |
| 6545022 |
4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
Apr. 8, 2003 |
| 6544970 |
Cyclic regimens utilizing indoline derivatives |
Apr. 8, 2003 |
| 6545021 |
Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections |
Apr. 8, 2003 |
| 6538008 |
Combination of a selective NMDA NR2B antagonist and an opioid analgesic |
Mar. 25, 2003 |
| 6531488 |
Method of treating neurodegenerative diseases |
Mar. 11, 2003 |
| 6531139 |
Self-emulsifying formulation for lipophilic compounds |
Mar. 11, 2003 |
| 6528528 |
Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis |
Mar. 4, 2003 |
| 6525087 |
Use of known agonists of the central cannabinoid receptor CB1 |
Feb. 25, 2003 |
| 6515024 |
Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
Feb. 4, 2003 |
| 6511991 |
Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
Jan. 28, 2003 |
| 6511979 |
Methods for treating conditions modulated by lactosylceramide |
Jan. 28, 2003 |
| 6509353 |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
Jan. 21, 2003 |
| 6506733 |
Compounds and compositions as protease inhibitors |
Jan. 14, 2003 |
|
|
|
